Canada · Delayed Price · Currency is CAD Cardiol Therapeutics Statistics
Total Valuation
TSX:CRDL has a market cap or net worth of CAD 149.67 million. The enterprise value is 131.62 million.
| Market Cap | 149.67M |
| Enterprise Value | 131.62M |
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:CRDL has 94.73 million shares outstanding. The number of shares has increased by 18.77% in one year.
| Current Share Class | 94.73M |
| Shares Outstanding | 94.73M |
| Shares Change (YoY) | +18.77% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 3.46% |
| Owned by Institutions (%) | 9.03% |
| Float | 91.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 12.68 |
| P/TBV Ratio | 12.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.51 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.24 |
Financial Position
The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.46 |
| Quick Ratio | 2.30 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -276.41% and return on invested capital (ROIC) is -183.05%.
| Return on Equity (ROE) | -276.41% |
| Return on Assets (ROA) | -108.74% |
| Return on Invested Capital (ROIC) | -183.05% |
| Return on Capital Employed (ROCE) | -337.69% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.09M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.52% in the last 52 weeks. The beta is 0.62, so TSX:CRDL's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -38.52% |
| 50-Day Moving Average | 1.54 |
| 200-Day Moving Average | 1.66 |
| Relative Strength Index (RSI) | 51.15 |
| Average Volume (20 Days) | 177,972 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -40.24M |
| Pretax Income | -37.55M |
| Net Income | -37.55M |
| EBITDA | -40.18M |
| EBIT | -40.24M |
| Earnings Per Share (EPS) | -0.48 |
Balance Sheet
The company has 18.20 million in cash and 142,554 in debt, giving a net cash position of 18.05 million or 0.19 per share.
| Cash & Cash Equivalents | 18.20M |
| Total Debt | 142,554 |
| Net Cash | 18.05M |
| Net Cash Per Share | 0.19 |
| Equity (Book Value) | 11.81M |
| Book Value Per Share | 0.14 |
| Working Capital | 11.75M |
Cash Flow
In the last 12 months, operating cash flow was -25.07 million and capital expenditures -32,408, giving a free cash flow of -25.10 million.
| Operating Cash Flow | -25.07M |
| Capital Expenditures | -32,408 |
| Free Cash Flow | -25.10M |
| FCF Per Share | -0.26 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:CRDL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.77% |
| Shareholder Yield | -18.77% |
| Earnings Yield | -25.09% |
| FCF Yield | -16.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |